Article
Establishment of a normal-derived estrogen receptor-positive cell line comparable to the prevailing human breast cancer subtype.
Oncotarget - 7 Feb 2017
Hopkinson Branden M, Klitgaard Marie C, Petersen Ole William, Villadsen René, Rønnov-Jessen Lone, Kim Jiyoung
Abstract excerpt
Understanding human cancer increasingly relies on insight gained from subtype specific comparisons between malignant and non-malignant cells. The most frequent subtype in breast cancer is the luminal. By far the most frequently used model for luminal breast cancer is the iconic estrogen receptor-positive (ERpos) MCF7 cell line. However, luminal specific comparisons have suffered from the lack of a relevant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
